Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

illuminate.health Selected as the Technology Platform of Choice to Power the Mednovate Connect Telepharmacy Solution

Mednovate’s Virtual Medication Management Services Bridge the Gap Between Patients and Pharmacists for Cost-Effective, Personalized Medication Therapy

illuminate.health, a digital health assistant platform designed to help people live healthier, announced that the company’s Med Guide medication therapy optimization offering will power Mednovate Connect, a real-time telepharmacy solution for medication management. Through Med Guide’s artificial intelligence (AI) platform integration with Mednovate, high-risk patient populations can virtually work with their pharmacist to create a personalized, cost-effective medication therapy plan. Patients are given increased access to care with capabilities to schedule telemedicine visits with pharmacists, ask drug-related questions and monitor their overall care progress.

Recommended AI News: Falcon Insurance Company Chooses Shift Technology For Fraud Detection

To support patient-driven medication management, Mednovate Connect realized early on that they needed a user-friendly telehealth solution to document medication therapy, improve patient adherence through a personal notification system, allow for pharmacist consults via text, video or phone and to be compatible with a patient’s electronic health record (EHR). Illuminate.health’s dynamic digital health assistant, Med Guide, proved to be an attractive solution to power this initiative as the tool, along with Mednovate’s trained clinical pharmacists, can help patients avoid medication-related complications and increase use of evidenced-based prescription routines to improve patient outcomes and reduce costs.

Related Posts
1 of 19,946

“Much of healthcare today is episodic but with Mednovate Connect powered by illuminate.health, we are excited about changing the model of medication use and monitoring. Now we can provide a continuous app that allows for a mediated patient medication optimization platform which connects patients and providers with clinical pharmacist experts,” explained Kenneth Dandurand R.PH, MS, President of Mednovate Connect. “The illuminate.health Med Guide app allows us to meet the groundbreaking developments in telehealth and provide virtual access during the COVID-19 pandemic to improve medication adherence, avoid adverse drug effects and reduce overall health costs for patient care.”

Recommended AI News: VIAVI Launches Comprehensive VPN Management Solution For Large To Medium Enterprises

“illuminate.health is humbled to be chosen as the platform of choice by Mednovate Connect to help patients reduce polypharmacy complications, provide personalized medication management services and to enable real-time access to care,” said Varun Goyal, CEO of illuminate.health. “We built Med Guide to help simplify complex medication regimens through personalized dosage schedules, which ultimately improves care guidance and instills trust and confidence in the medication therapy. Through our platform, pharmacists are granted easier and better access to patients and provided with information about overall patient health to inform clinical decisions.”

This combined effort will be a game changer for health plans, self-insured employers and healthcare organizations in controlling drug costs and improving patient medication use and outcomes.

Recommended AI News: CenturyLink Helps Fuel Kid’s Bodies And Minds During Uncertain Times

Leave A Reply

Your email address will not be published.